Unknown

Dataset Information

0

Prospective randomized trial of continuous femoral nerve block with posterior capsular injection versus periarticular injection for analgesia in primary total knee arthroplasty.


ABSTRACT:

Background

Femoral nerve block (NB) and periarticular injection (PI) are 2 common options for pain control after total knee arthroplasty (TKA). We performed a prospective triple-blinded randomized trial comparing continuous femoral NB to PI, with follow-up to 1 year.

Methods

Patients younger than 70 years of age who were scheduled to undergo elective primary TKA under spinal anesthesia between 2009 and 2010 were randomly allocated to receive either continuous femoral NB or PI. Patients in the NB group received ropivacaine through an NB catheter and a sham saline PI. The PI group received a PI of ropivacaine, morphine, ketorolac and epinephrine, and a sham saline infusion via an NB catheter. Both groups had standardized oral analgesia preoperatively, spinal anesthesia and sedation, and postoperative analgesia. Surgeons, anesthesiologists, patients and assessors were blinded to group assignment. Pain was measured twice daily on postoperative days 1 and 2, at rest and with motion, with a numeric rating scale. Patient satisfaction, pain (Oxford Knee Score) and range of motion were assessed at 1 year.

Results

There were 39 participants in the NB group and 35 participants in the PI group. There were no statistically significant differences between the groups at baseline. Statistically but nonclinically significant reductions in pain scores on postoperative day 2 and in narcotic need on the day of surgery were found in the PI group. Patient-reported satisfaction did not differ at any time point. At 1 year, knee flexion was significantly greater in the NB group than in the PI group (mean range of motion 120° v. 110°, p = 0.03).

Conclusion

There was no demonstrated improvement in pain control with the use of an NB versus PI when used with multimodal analgesia. Clinicians should opt for the modality that has the best efficiency for their surgical environment. ClinicalTrials.gov # NCT00869037

SUBMITTER: Aragola S 

PROVIDER: S-EPMC8327987 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3971237 | biostudies-literature
| S-EPMC4958110 | biostudies-literature
| S-EPMC7041113 | biostudies-literature
| S-EPMC4691770 | biostudies-literature
| S-EPMC7534509 | biostudies-literature
| S-EPMC7507271 | biostudies-literature
| S-EPMC4947328 | biostudies-other
| S-EPMC3132825 | biostudies-literature
| S-EPMC5298367 | biostudies-literature
| S-EPMC3237035 | biostudies-literature